Elevated concentrations or enzymatic activity of VAP-1/SSAO have been observed in patients with tobacco use, atherosclerosis, hypertension, heart failure, aortic stenosis, coronary artery disease, and diabetes mellitus, potentially leading to enhanced conversion of methylamine and aminoacetone (64–71). The gene discussed is AOC3; the disease is coronary artery disorder.